These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 24784427

  • 21. Reinventing bioinnovation.
    Kaitin KI, Honig PK.
    Clin Pharmacol Ther; 2013 Sep; 94(3):279-83. PubMed ID: 23963211
    [Abstract] [Full Text] [Related]

  • 22. The critical impact of time discounting on economic incentives to overcome the antibiotic market failure.
    Spellberg B, Sharma P, Rex JH.
    Nat Rev Drug Discov; 2012 Feb 01; 11(2):168. PubMed ID: 22293569
    [No Abstract] [Full Text] [Related]

  • 23. The antibiotic pipeline--challenges, costs, and values.
    Wenzel RP.
    N Engl J Med; 2004 Aug 05; 351(6):523-6. PubMed ID: 15295041
    [No Abstract] [Full Text] [Related]

  • 24. Antibiotics: a shot in the arm.
    Leeb M.
    Nature; 2004 Oct 21; 431(7011):892-3. PubMed ID: 15496888
    [No Abstract] [Full Text] [Related]

  • 25. Repairing the broken market for antibiotic innovation.
    Outterson K, Powers JH, Daniel GW, McClellan MB.
    Health Aff (Millwood); 2015 Feb 21; 34(2):277-85. PubMed ID: 25646108
    [Abstract] [Full Text] [Related]

  • 26. Perspective: Graduation time.
    Russell DG, Nathan CF.
    Nature; 2013 Oct 10; 502(7470):S7. PubMed ID: 24108080
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Is the GAIN Act a turning point in new antibiotic discovery?
    Brown ED.
    Can J Microbiol; 2013 Mar 10; 59(3):153-6. PubMed ID: 23540332
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Open innovation: public-private partnerships in pharmaceutical R&D].
    Uchibayashi N.
    Nihon Yakurigaku Zasshi; 2013 Jul 10; 142(1):32-8. PubMed ID: 23842226
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Improving antibiotic markets for long-term sustainability.
    Kesselheim AS, Outterson K.
    Yale J Health Policy Law Ethics; 2011 Jul 10; 11(1):101-67. PubMed ID: 21381513
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.